Previous research hinted that small cell cancers from different organs may be driven by common mechanisms, but the new study is the first to so clearly describe the steps in their evolution.
The research is the first of its kind to compare results between radiotherapy treatments that are higher than the standard dose and traditional treatments, such as radiation and prostatectomy.
UCLA researchers have discovered a previously unrecognized type of progenitor cell that is found in uncommonly high numbers in inflamed areas of the gland.
The researchers found that an experimental drug called CD532, which changes the structure of a key protein, reduced the size of tumors in mice by 80 percent.
For the first time, researchers have described the cost throughout the entire treatment process — from the initial doctor’s visit to follow-up appointments.
Researchers say this research gives important insight into the cellular nature of aggressive prostate cancer, which will aid in the development of better treatments.